Work

Evaluation of epidermal growth factor receptor (EGFR) as a predictive marker in patients with non-small-cell lung cancer (NSCLC) receiving first-line gefitinib combined with platinum-based chemotherapy

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.7013

Authors: L. R. Bailey, M. Janas, K. Schmidt, N. Bindslev, M. Wolf, J. Grous, J. Askaa, R. Herbst, D. H. Johnson, G. Giaccone

Institutions: The University of Texas MD Anderson Cancer Center, Vanderbilt University, AstraZeneca (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2244823046

Cites:

Cited by: 38

Related to: 10